Patents by Inventor Robert Marshall

Robert Marshall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090325993
    Abstract: Compounds of formula (I) or a salt thereof are provided: wherein R1, R2, R3, R4, R5, R6, R7, R9, R10, X, n, p and m are as defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicament for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder are also disclosed. The invention further discloses pharmaceutical compositions and combinations comprising the compounds.
    Type: Application
    Filed: January 30, 2008
    Publication date: December 31, 2009
    Inventors: Nadia Mamoona Ahmad, Justine Yeun Quai Lai, Howard Robert Marshall, David John Nash, Roderick Alan Porter
  • Publication number: 20090286828
    Abstract: The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.
    Type: Application
    Filed: December 21, 2005
    Publication date: November 19, 2009
    Inventors: Andrea Bozzoli, Clive Leslie Branch, Jacqueline Anne Macritchie, Howard Robert Marshall, Roderick Alan Porter, Simone Spada
  • Publication number: 20090270510
    Abstract: The present invention relates to compounds of formula (I), or salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.
    Type: Application
    Filed: December 21, 2005
    Publication date: October 29, 2009
    Applicant: GLAXO GROUP LIMITED
    Inventors: Daniel Marcus Bradley, Clive Leslie Branch, Wai Ngor Chan, Steven Coulton, Martin Leonard Gilpin, Andrew Jonathan Harris, Justine Yeun Quai Lai, Jacqueline Anne Macritchie, Howard Robert Marshall, David John Nash, Roderick Alan Porter, Simone Spada, Kevin Michael Thewlis, Simon Edward Ward
  • Patent number: 7592927
    Abstract: A system and method for controlling transportation traffic signal beacons including powering a signal, encoding a signal state, and decoding the signal state at the beacon is presented. Furthermore, traffic signal beacons may be placed along the length of a bridge to warn of a bridge collapse. The metallic cable that powers the beacons may also function as a bridge collapse detection sensor.
    Type: Grant
    Filed: December 2, 2005
    Date of Patent: September 22, 2009
    Inventors: Robert A Marshall, Fred R Marshall
  • Publication number: 20090208734
    Abstract: Various embodiments of a technique in which test strip lots can be prepared without requiring a user to input any calibration information before performing a test measurement with a test strip from the test strip lots. In a first aspect, a method of manufacturing a plurality of test strips by adjusting amount of mediators and working electrode area is described. In another aspect, a method of preparing a reagent ink by adjusting the density of the reagent ink to substantially match a target density is described. In a further aspect, a method using a high numerical Shores Hardness squeegee in conjunction with high pressure is provided. In a further aspect, a method of performing an analyte measurement with a test meter, the test meter being configured to not receive a calibration input, and where the test strip manufactured to any one of the methods or techniques described and illustrated herein.
    Type: Application
    Filed: January 15, 2009
    Publication date: August 20, 2009
    Inventors: Gavin MACFIE, Robert MARSHALL, Manuel ALVAREZ-ICAZA, Kevin DELANEY, Keith DUFFUS, Tim JARVIS, Martin LAMACKA, Nicholas PHIPPEN, Robert RUSSELL
  • Publication number: 20090160303
    Abstract: A geometrically shaped photonic crystal structure consisting of alternating layers of thin films is heated to emit light. The structure may include index matching layers or a cavity layer to enhance emissions. The layer thicknesses of the structure may be spatially varied to modify the emission spectrum versus emission angle. The self-focusing structure may be fabricated into a convex electrically heated wire filament light bulb, a concave visible thermophotovoltaic emitter, a concentric directional heat exchanger, an electronic display, or a variety of irregularly shaped remotely read temperature or strain sensors.
    Type: Application
    Filed: December 20, 2007
    Publication date: June 25, 2009
    Inventor: Robert A. Marshall
  • Patent number: 7509505
    Abstract: A method for managing the delivery of power for a plurality of devices includes allocating a power limit for each of the plurality of devices and providing power to at least one of the plurality of devices. The method also includes, in response to the providing of power, measuring the amount of power utilized by each of at least one of the at least one of the plurality of devices and determining that the amount of power exceeds the power limit for the device.
    Type: Grant
    Filed: January 4, 2005
    Date of Patent: March 24, 2009
    Assignee: Cisco Technology, Inc.
    Inventors: Anthony L. Randall, Robert A. Marshall, Rachel C. Neal
  • Publication number: 20090062360
    Abstract: Compounds of formula (I) and salts and solvates thereof are provided: wherein R1 to R8 and n are defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicament for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder are also disclosed. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.
    Type: Application
    Filed: March 14, 2007
    Publication date: March 5, 2009
    Inventors: Steven Coulton, Howard Robert Marshall, David John Nash, Roderick Alan Porter
  • Patent number: 7500006
    Abstract: One embodiment of an inventive networking environment includes clients called sending clients because they send network content through a network, and clients called receiving clients because they receive the network content from the sending clients through the network. Both sending clients and receiving clients are “clients” in that they rely on a management server to orchestrate the secure transfer of information from sending clients to receiving clients.
    Type: Grant
    Filed: June 29, 2005
    Date of Patent: March 3, 2009
    Assignee: Intertrust Technologies Corp.
    Inventors: George H. Peden, Robert A. Marshall
  • Patent number: 7495788
    Abstract: A system is provided for dispatching one or more packets of information selected from the group consisting of redeemable coupons, messages, appointment reminders, confirmations, tickets, warnings and written packets to potential recipients of said packets at a remote location. The steps included in such a system are: (1) developing a subscriber directory containing unique identification information for each of said potential recipients; (2) creating a packet to be dispatched to at least one of said recipients; (3) identifying the potential recipients for a particular packet; (4) transmitting said packet through a pager network to all of said potential recipients; and (5) receiving and selectively processing and printing only those packets intended to be processed and printed by said appliance.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: February 24, 2009
    Assignee: NCH Marketing Services, Inc.
    Inventors: Robert T. Kulakowski, Robert Marshall, George Rogers
  • Publication number: 20080310143
    Abstract: A device for use in a restaurant as a source of light for the table area comprising a housing, a power circuit and at least one light source. The housing has an integral base that is configured to support the housing on a table. The power circuit has a power source positioned therein the housing and a pressure switch. The at least one light source is positioned therein the housing proximate an aperture in the base and is electrically coupled to the power circuit. The pressure switch is configured to selectively open and close the power circuit such that the at least one light source can be selectively energized by either placing the housing on the table, such that the at least one light source is in a de-energized position, or lifting the housing upwardly away from the table, which energizes the at least one light source.
    Type: Application
    Filed: June 12, 2008
    Publication date: December 18, 2008
    Inventor: Robert Marshall Barker
  • Publication number: 20080288794
    Abstract: A method for managing the delivery of power for a plurality of devices includes allocating a power limit for each of the plurality of devices and providing power to at least one of the plurality of devices. The method also includes, in response to the providing of power, measuring the amount of power utilized by each of at least one of the at least one of the plurality of devices and determining that the amount of power exceeds the power limit for the device.
    Type: Application
    Filed: July 31, 2008
    Publication date: November 20, 2008
    Applicant: CISCO TECHNOLOGY, INC.
    Inventors: Anthony L. Randall, Robert A. Marshall, Rachel C. Neal
  • Publication number: 20080287547
    Abstract: The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.
    Type: Application
    Filed: December 21, 2005
    Publication date: November 20, 2008
    Inventors: Daniel Marcus Bradley, Clive Leslie Branch, Wai Ngor Chan, Steven Coulton, Martin Leonard Gilpin, Andrew Jonathan Harris, Albert Andrzej Jaxa-Chamiec, Justine Yeun Quai Lai, Jacqueline Anne Macritchie, Howard Robert Marshall, David John Nash, Roderick Alan Porter, Simone Spada, Kevin Michael Thewlis, Simon Edward Ward
  • Publication number: 20080275365
    Abstract: Disclosed are various preferred embodiments for dynamic transfer of information from a test sensor to an analyte medical test device. Exemplary embodiments include various containers, systems and methods.
    Type: Application
    Filed: May 4, 2007
    Publication date: November 6, 2008
    Inventors: Brian Guthrie, Eng Kim Shuy, Gordon George Sansom, David Taylor, Keith Torrie, Robert Marshall, David Howarth, Emma Day
  • Publication number: 20080274552
    Abstract: Disclosed are various preferred embodiments for dynamic transfer of information from a test sensor to an analyte medical test device. Exemplary embodiments include various containers, systems and methods.
    Type: Application
    Filed: May 4, 2007
    Publication date: November 6, 2008
    Inventors: Brian Guthrie, Eng Kim Shuy, Gordon George Sansom, David Taylor, Keith Torrie, Robert Marshall, David Howarth, Emma Day
  • Publication number: 20080255144
    Abstract: The invention provides a compound of formula (I) or a salt or solvate thereof: wherein R1, n, X, Y and Z are as defined in the specification, and uses of such compounds. The compounds inhibit GlyT1 transporters and are useful in the treatment of certain neurological and neuropsychiatric disorders, including schizophrenia.
    Type: Application
    Filed: March 9, 2006
    Publication date: October 16, 2008
    Inventors: Daniel Marcus Bradley, Clive Leslie Branch, Wai Ngor Chan, Steven Coulton, Anthony William Dean, Paul Martin Doyle, Brian Evans, Martin Leonard Gilpin, Sharon Lisa Gough, Jacqueline Anne Macritchie, Howard Robert Marshall, David John Nash, Roderick Alan Porter, Simon Edward Ward
  • Publication number: 20080103145
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. Examples of such compounds include reboxetine, and more particularly racemic reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 1, 2008
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor, Lars Birgerson, Pasquale Cetera
  • Publication number: 20080103147
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. Examples of such compounds include reboxetine, and more particularly racemic reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 1, 2008
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor, Lars Birgerson, Pasquale Cetera
  • Publication number: 20080103146
    Abstract: Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 1, 2008
    Inventors: Erik Wong, Saeeduddin Ahmed, Robert Marshall, Robert McArthur, Duncan Taylor, Lars Birgerson, Pasquale Cetera
  • Patent number: D569577
    Type: Grant
    Filed: June 5, 2007
    Date of Patent: May 27, 2008
    Inventor: Robert Marshall Barker